Panaji: The response to the tuberculosis prevention vaccine, Bacillus Calmette-Guerin (BCG), introduced in South Goa in 2024, ...

While hopeful that the BCG vaccine will prove to be effective against Covid-19 – as with any of the treatments and vaccines under development – Dr. William Schaffner, an infectious disease ...

BCG, or Bacillus Calmette-Guérin, is a cheap and safe vaccine that was first developed in the 1920s as a defense against tuberculosis (TB) – a bacterial lung infection.

The bacille Calmette–Guérin (BCG) vaccine has immunomodulatory “off-target” effects that have been hypothesized to protect against coronavirus disease 2019 (Covid-19).In this international ...

BCG, a century-old vaccine for tuberculosis, is in the news, raising hopes for the COVID-19 pandemic. But existing ecological studies have serious limitations. Randomized trials are urgently needed.

The BCG vaccine is considered safe with rare side effects, but it’s not very effective. One meta-analysis of 26 studies reported that when the BCG vaccine was given during infancy, ...

The BCG vaccine was developed to protect against tuberculosis, which is also known as TB. It was launched in 1921 and is typically administered to adults aged 16 to 35 who might be at risk of TB ...

The BCG vaccine is built fairly differently from the Pfizer and Moderna Covid vaccines, which have been similarly effective against the virus. Instead of mRNA, ...

Because BCG is a generic vaccine costing an average of 50 cents a dose, there is little incentive for drug developers to pour money into studies for new uses.

More than 20 COVID-19 vaccine candidates are in development right now, and the World Health Organization (WHO) said it will work on an initiative to make the new drugs widely available once they ...

There is currently no vaccine or treatments approved by the US Food and Drug Administration for the novel coronavirus. While hopeful that the BCG vaccine will prove to be effective against Covid ...